Associations of Gender and Age with the Reporting of Drug‐Induced Hepatic Failure: Data from the VigiBase™

Patient gender and age are considered to be the risk factors for developing drug‐induced liver injury (DILI). The aim of this study was to analyze gender and age differences in reporting of drug‐induced hepatic failure (HF) to the VigiBase™. VigiBase™ was screened for the HF reports submitted from 2000 to 2009. The information retrieved referred to the suspected drug, age, gender, and a reporting country. Variables were examined by using descriptive statistics and the binomial test. During the 10‐year period there were in total 6 370 HF reports from 38 countries. After the exclusion of cases with missing gender data (379 cases), females counted for 54.03%. The largest portion of HF cases referred to age <55 (42.57%) with female predominance (56.81%), whereas age ≥55 (32.57%) showed almost even gender distribution. Overall, there were 941 different drugs or their combinations reported. Females significantly predominated in HF cases associated with analgesics, antiepileptics, antiinflamatory and antirheumatic drugs, psychoanaleptics, antibacterials for systemic use, and antidiabetic drugs. Males were significantly overrepresented in HF cases associated with antivirals for systemic use. Differences between genders and/or age groups in the reporting of drug‐induced HF depend on drug and/or drug class but may be influenced by multiple factors.

[1]  G. Danan,et al.  Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. , 1993, Journal of clinical epidemiology.

[2]  Michael P Holt,et al.  Drug-induced liver injury. , 2010, Handbook of experimental pharmacology.

[3]  D. Pessayre,et al.  Effects of female sex hormones on mitochondria: possible role in acute fatty liver of pregnancy. , 1995, The American journal of physiology.

[4]  D. Pessayre,et al.  Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity. , 1995, Pharmacology & therapeutics.

[5]  W. Fleischhacker,et al.  Hepatotoxicity of clozapine , 1996, Schizophrenia Research.

[6]  M. Black,et al.  Drug induced liver disease. , 1983, Postgraduate medical journal.

[7]  William M. Lee,et al.  Results of a Prospective Study of Acute Liver Failure at 17 Tertiary Care Centers in the United States , 2002, Annals of Internal Medicine.

[8]  R. Fontana,et al.  Polymerase γ Gene POLG determines the risk of sodium valproate‐induced liver toxicity , 2010, Hepatology.

[9]  E. Björnsson.  Hepatotoxicity associated with antiepileptic drugs , 2008, Acta neurologica Scandinavica.

[10]  C. Kuehner.  Gender differences in unipolar depression: an update of epidemiological findings and possible explanations , 2003, Acta psychiatrica Scandinavica.

[11]  K. Böker,et al.  Akutes Leberversagen , 2001, Der Internist.

[12]  Betsy Foxman,et al.  The epidemiology of urinary tract infection , 2010, Nature Reviews Urology.

[13]  N. Chalasani,et al.  Risk factors for idiosyncratic drug-induced liver injury. , 2010, Gastroenterology.

[14]  E. Björnsson,et al.  The impact of eosinophilia and hepatic necrosis on prognosis in patients with drug‐induced liver injury , 2007, Alimentary pharmacology & therapeutics.

[15]  G. Auzinger,et al.  Prognostic utility of the bilirubin lactate and etiology score. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[16]  R. Andrade,et al.  Phenotypic characterization of idiosyncratic drug‐induced liver injury: The influence of age and sex , 2009, Hepatology.

[17]  A. Suzuki,et al.  Drug induced hepatotoxicity: data from the Serbian pharmacovigilance database , 2011, Pharmacoepidemiology and drug safety.

[18]  P. Hillon,et al.  Incidence of drug‐induced hepatic injuries: A French population‐based study , 2002, Hepatology.

[19]  D. Isacson,et al.  Epidemiology of analgesic use: a gender perspective , 2002, European journal of anaesthesiology. Supplement.

[20]  A. Bergquist,et al.  Acute liver failure in Sweden: etiology and outcome , 2007, Journal of internal medicine.

[21]  E. Björnsson,et al.  Suspected drug-induced liver fatalities reported to the WHO database. , 2006, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[22]  William M. Lee,et al.  Acetaminophen‐induced acute liver failure: Results of a United States multicenter, prospective study , 2005, Hepatology.

[23]  D. Makuc,et al.  Health, United States, 2010; with special feature on death and dying , 2011 .

[24]  William M. Lee,et al.  Drug‐induced acute liver failure: Results of a U.S. multicenter, prospective study , 2010, Hepatology.

[25]  R. Andrade,et al.  Drug-induced hepatotoxicity , 2003, The New England journal of medicine.

[26]  Ignazio Grattagliano,et al.  Current Concepts of Mechanisms in Drug-Induced Hepatotoxicity , 2009, Current medicinal chemistry.

[27]  E. Björnsson,et al.  Fulminant drug-induced hepatic failure leading to death or liver transplantation in Sweden , 2005, Scandinavian journal of gastroenterology.

[28]  E. Björnsson,et al.  Outcome and prognostic markers in severe drug‐induced liver disease , 2005, Hepatology.

[29]  V. Balan,et al.  Inpatient Admissions for Drug-induced Liver Injury: Results from a Single Center , 2008, Digestive Diseases and Sciences.

[30]  B. Pollock,et al.  Sex differences in the pharmacokinetics and pharmacodynamics of antidepressants: an updated review. , 2009, Gender medicine.

[31]  O. Cope,et al.  Multiple myeloma. , 1948, The New England journal of medicine.

[32]  V. Navarro,et al.  Review article: drug‐induced liver injury – its pathophysiology and evolving diagnostic tools , 2011, Alimentary pharmacology & therapeutics.

[33]  M. Lindquist.  VigiBase, the WHO Global ICSR Database System: Basic Facts , 2008 .

[34]  N. Kaplowitz,et al.  Drug-Induced Liver Disease, Second Edition , 2002 .

[35]  Luis Rodrigo,et al.  Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. , 2005, Gastroenterology.